WO2002046380A3 - Protein kinase - Google Patents

Protein kinase Download PDF

Info

Publication number
WO2002046380A3
WO2002046380A3 PCT/GB2001/005348 GB0105348W WO0246380A3 WO 2002046380 A3 WO2002046380 A3 WO 2002046380A3 GB 0105348 W GB0105348 W GB 0105348W WO 0246380 A3 WO0246380 A3 WO 0246380A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein kinase
protein
termed
diagnosis
proteins
Prior art date
Application number
PCT/GB2001/005348
Other languages
French (fr)
Other versions
WO2002046380A2 (en
Inventor
Christopher Benjamin Phelps
Richard Joseph Fagan
Original Assignee
Inpharmatica Ltd
Christopher Benjamin Phelps
Richard Joseph Fagan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inpharmatica Ltd, Christopher Benjamin Phelps, Richard Joseph Fagan filed Critical Inpharmatica Ltd
Priority to AU2002222122A priority Critical patent/AU2002222122A1/en
Publication of WO2002046380A2 publication Critical patent/WO2002046380A2/en
Publication of WO2002046380A3 publication Critical patent/WO2002046380A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

This invention relates to a novel protein, termed BAA77392.1, herein identified as a protein kinase and to the use of this proteins and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
PCT/GB2001/005348 2000-12-04 2001-12-04 Protein kinase WO2002046380A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002222122A AU2002222122A1 (en) 2000-12-04 2001-12-04 Protein kinase

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0029549.3 2000-12-04
GB0029549A GB0029549D0 (en) 2000-12-04 2000-12-04 Novel protein

Publications (2)

Publication Number Publication Date
WO2002046380A2 WO2002046380A2 (en) 2002-06-13
WO2002046380A3 true WO2002046380A3 (en) 2003-02-06

Family

ID=9904409

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/005348 WO2002046380A2 (en) 2000-12-04 2001-12-04 Protein kinase

Country Status (3)

Country Link
AU (1) AU2002222122A1 (en)
GB (1) GB0029549D0 (en)
WO (1) WO2002046380A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (en) * 1998-05-14 1999-11-18 Chiron Corporation Human genes and gene expression products v
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058675A2 (en) * 1998-05-14 1999-11-18 Chiron Corporation Human genes and gene expression products v
EP1074617A2 (en) * 1999-07-29 2001-02-07 Helix Research Institute Primers for synthesising full-length cDNA and their use

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 November 1999 (1999-11-01), XP002211139, Database accession no. Q9Y6Y8 *
DATABASE EMBL [online] 10 May 1999 (1999-05-10), XP002211140, Database accession no. AB019435 *
DATABASE EMBL [online] 26 January 2001 (2001-01-26), XP002211141, Database accession no. AAB92643 *
DATABASE EMBL [online] 26 January 2001 (2001-01-26), XP002211142, Database accession no. AAH13939 *
TANI KATSUKO ET AL: "p125 is a novel mammalian Sec23p-interacting protein with structural similarity to phospholipid-modifying proteins.", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 274, no. 29, 16 July 1999 (1999-07-16), pages 20505 - 20512, XP002211138, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
WO2002046380A2 (en) 2002-06-13
AU2002222122A1 (en) 2002-06-18
GB0029549D0 (en) 2001-01-17

Similar Documents

Publication Publication Date Title
WO2001066753A3 (en) Human genes and gene expression products
WO2003054012A3 (en) Leptin proteins
WO2004096856A3 (en) Secreted protein family
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2002070563A3 (en) Nuclear hormone receptor ligand binding domain
WO2002046380A3 (en) Protein kinase
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2001072781A3 (en) Human genes and expression products
WO2002034901A8 (en) Protein kinase
WO2004053117A3 (en) Serine protease
WO2004056983A3 (en) Metalloprotease proteins
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
WO2002070560A3 (en) Nuclear hormone receptor ligand binding domain
WO2002050116A3 (en) Adhesion molecule protein
WO2002062845A3 (en) Adhesion molecules
WO2002029023A8 (en) Nicastrin protein
WO2002044382A8 (en) Cytokine-like proteins
WO2004050703A8 (en) Splice variant of the human pituitary growth hormone
WO2002088341A3 (en) P450 proteins
WO2004009633A8 (en) Serotonin receptor
WO2002062976A3 (en) Serine proteases
WO2004003011A3 (en) Nuclear hormone receptor
WO2004024762A3 (en) Il-8 like protein
WO2004016654A8 (en) Il-8 like protein
WO2004101618A3 (en) Progestin-yol002c-cgi-45 receptor-related proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP